BioStem Technologies, Inc. (BSEM)
OTCMKTS · Delayed Price · Currency is USD
5.50
-0.28 (-4.89%)
Mar 5, 2026, 3:58 PM EST
BioStem Technologies Market Cap
BioStem Technologies has a market cap or net worth of $92.28 million as of March 5, 2026. Its market cap has decreased by -62.81% in one year.
Market Cap
92.28M
Enterprise Value
68.51M
Revenue
292.21M
Ranking
n/a
PE Ratio
6.43
Stock Price
$5.50
Market Cap Chart
Since August 4, 2009, BioStem Technologies's market cap has increased from 4.77M to 92.28M, an increase of 1,832.85%. That is a compound annual growth rate of 19.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 97.20M | 51.85% |
| Dec 31, 2025 | 64.01M | -72.22% |
| Dec 31, 2024 | 230.43M | 143.12% |
| Dec 29, 2023 | 94.78M | 160.66% |
| Dec 30, 2022 | 36.36M | 267.00% |
| Dec 30, 2021 | 9.91M | -25.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 361.40M |
| CytoDyn | 296.04M |
| Silence Therapeutics | 267.58M |
| Vaxart | 180.09M |
| HST Global | 70.56M |
| Nuo Therapeutics | 67.60M |
| Vicapsys Life Sciences | 48.56M |
| Cell Source | 41.50M |